Modeling & Informatics at Vertex Pharmaceuticals Incorporated: our philosophy for sustained impact
Related Experiment Video
Updated: Oct 9, 2026

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate
Published on: October 29, 2021
Georgia McGaughey1, W Patrick Walters2
1Vertex Pharmaceuticals Inc., Boston, MA, USA. georgia_mcgaughey@vrtx.com.
Abstract:
Molecular modelers and informaticians have the unique opportunity to integrate cross-functional data using a myriad of tools, methods and visuals to generate information. Using their drug discovery expertise, information is transformed to knowledge that impacts drug discovery. These insights are often times formulated locally and then applied more broadly, which influence the discovery of new medicines. This is particularly true in an organization where the members are exposed to projects throughout an organization, such as in the case of the global Modeling & Informatics group at Vertex Pharmaceuticals. From its inception, Vertex has been a leader in the development and use of computational methods for drug discovery. In this paper, we describe the Modeling & Informatics group at Vertex and the underlying philosophy, which has driven this team to sustain impact on the discovery of first-in-class transformative medicines.
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model Approaches for Pharmacokinetic Data: Physiological Models
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Pharmacodynamic Models: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Production of Pharmaceuticals